AvePoint Inc
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
AVPT$16.89+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(In thousands)
| For the Year Ended | |||
|---|---|---|---|
| December 31, | |||
| 2024 | 2023 | 2022 | |
| Operating activities | |||
| Net loss | $(29,142) | $(21,501) | $(38,688) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 5,382 | 4,687 | 3,494 |
| Operating lease right-of-use assets expense | 6,270 | 6,234 | 5,945 |
| Foreign currency remeasurement loss | 866 | — | 835 |
| Stock-based compensation | 39,059 | 36,048 | 37,218 |
| Deferred income taxes | 498 | (864) | 3,701 |
| Other | (67) | 1,068 | (607) |
| Change in value of earn-out and warrant liabilities | 37,276 | 11,454 | (4,402) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (4,898) | (19,448) | (14,388) |
| Prepaid expenses and other current assets | (3,350) | (2,773) | (2,108) |
| Deferred contract costs and other assets | (8,482) | (7,687) | (9,596) |
| Accounts payable, accrued expenses and other current liabilities, operating lease liabilities and other liabilities | 16,046 | 609 | (2,553) |
| Deferred revenue | 29,436 | 26,867 | 20,375 |
| Net cash provided by (used in) operating activities | 88,894 | 34,694 | (774) |
| Investing activities | |||
| Maturities of investments | 5,353 | 2,620 | 183,554 |
| Purchases of investments | (1,819) | (3,497) | (180,969) |
| Cash paid in business combinations and asset acquisitions, net of cash acquired | — | — | (18,572) |
| Capitalization of internal-use software | (1,211) | (1,434) | (1,612) |
| Purchase of property and equipment | (3,044) | (2,087) | (3,853) |
| Issuance of notes receivables | (1,750) | (1,250) | — |
| Other investing activities | (130) | — | — |
| Net cash used in investing activities | (2,601) | (5,648) | (21,452) |
| Financing activities | |||
| Purchase of common stock | (33,053) | (39,036) | (19,927) |
| Proceeds from warrant exercises | 17,182 | — | — |
| Proceeds from stock option exercises | 11,033 | 5,569 | 2,818 |
| Redemption of redeemable noncontrolling interest | (6,130) | — | — |
| Purchase of public warrants | (3,991) | — | — |
| Company earn-out shares settled in cash | (572) | — | — |
| Repayments of finance leases | (6) | (64) | (39) |
| Payments of debt issuance costs | — | (136) | — |
| Net cash used in financing activities | (15,537) | (33,667) | (17,148) |
| Effect of exchange rates on cash | (3,183) | 595 | (1,655) |
| Net increase (decrease) in cash and cash equivalents | 67,573 | (4,026) | (41,029) |
| Cash and cash equivalents at beginning of period | 223,162 | 227,188 | 268,217 |
| Cash and cash equivalents at end of period | $290,735 | $223,162 | $227,188 |
| Supplemental disclosures of cash flow information | |||
| Income taxes paid | $6,882 | $6,112 | $3,320 |
| Contingent considerations in business combination | $— | $— | $5,635 |
| Common stock issued in business combination | $— | $— | $1,517 |
| Loan to certain acquiree shareholders | $— | $— | $235 |
| Company earn-out shares issuance | $53,871 | $— | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.